About sanare

Who We Are

At Sanare Oncology, we believe cancer care shouldn't start with a diagnosis—it should begin with prevention and extend through every stage of survivorship. We are a concierge medical platform that merges the power of precision diagnostics, functional medicine, and AI-driven insights to deliver deeply personalized, proactive care.

Rooted in science and guided by compassion, we help individuals prevent cancer, navigate life after treatment, and thrive in their health journey. Our virtual-first model ensures expert support, cutting-edge testing, and curated wellness plans—accessible from anywhere, at any time.
Book a Virtual Visit
What we stand for

Our Core Values

Accessibility
Healthcare should be available to everyone, anytime, anywhere.
Personalization
Your health journey is unique, and we tailor
our care to suit your individual needs.
Empathy
Compassionate care is at the core of
everything we do.
Innovation
Using advanced technology to deliver seamless and effective healthcare solutions.
Preventative Care
We focus on proactive measures to keep
you healthy and thriving.
Collaboration
We partner with you and your care team
to ensure the best outcomes.
Why it Works

Not Just Treatment. Transformation

Concierge Oncology
Rooted in Science, Guided by Soul.
Built by Oncology Experts
Created by a precision oncology clinical trials leader and AI strategist
Rooted in Evidence + Empathy
Every recommendation combines NCCN-backed science with whole-body insight
Real-Time Personalization
Plans update dynamically as your health changes — because healing is not static
SANARE ONCOLOGY SERVICES

Your Care, Simplified

Cancer Prevention

  • AI Risk ModelingGenetic
  • Genomic TestingFull-body Imaging
  • Full-body Imaging + Galleri Test
  • Concierge Lab Services (Home/Office)

Cancer Survivorship

  • Recurrence Monitoring
  • Metabolic, Hormonal, and Microbiome Optimization
  • Mental Resilience + Rehab Tools
  • Continuous AI Tracking

Precision Oncology Tools

  • AI Health Insights Dashboard
  • Immune Mapping + Biomarkers
  • Personalized Supplement Plan

Telehealth Oncology

  • Virtual Consults
  • Second Opinions
  • Plan Monitoring + Adjustments

Innovative Therapies & Research

  • Clinical Trial Access
  • Anti-Aging + Regenerative Oncology Tools

We’re not just changing how cancer care is delivered. We’re redefining what it means to heal.

Our mission

Empowering people at every stage
of the cancer journey through expert-led,
AI-enhanced, personalized oncology.

To transform the cancer journey—before, during, and after—through personalized, concierge medical care that combines functional health, advanced diagnostics, and AI-driven precision to prevent disease, optimize survivorship, and empower lifelong wellness.
Our Vision

A Future Without Fear

To create a world where cancer prevention and recovery are intelligent, accessible, and life-changing.

Join the Waitlist

Meet Our Founder

Headshot of the founder of Sanare, Dr. Arisha Patel
Dr. Arisha Patel, MD, MBA
Founder & CEO  |  Board-Certified Oncologist  |  Physician-Scientist  |  Data Strategist

“Sanare Oncology was born from a vision to reimagine cancer care—one where precision diagnostics, AI-powered insights, and human connection converge. Whether in genetics, imaging, biomarkers, or lived experience, your story holds insights. At Sanare Oncology, we translate that story into a roadmap using AI, expert care, and the healing power of nature and community. Transformation is not just possible—it’s personalized.”

Dr. Arisha Patel is a board-certified oncologist, physician-scientist, and data strategist with over a decade of leadership in precision oncology. She has led molecular trials, shaped national treatment guidelines, and helped pioneer the real-world integration of tumor-agnostic care and AI-powered diagnostics into clinical workflows.Through Sanare Oncology and its sister practice Sanare Hematology, she is reimagining what comes next—not just in treatment, but in the entire lifecycle of survivorship and prevention. Her mission is to infuse evidence-based science with real-time AI insights, longevity protocols, and whole-person digital care to deliver deeply transformative, human-centered cancer wellness.

Dr. Patel holds her MD from Chicago Medical School, completed fellowship at UPMC (a National Cancer Institute-designated Comprehensive Cancer Center and member of the National Comprehensive Cancer Network), and earned her MBA in Biomedical Entrepreneurship from Carnegie Mellon University. She has served as adjunct faculty at distinguished academic institutions, led strategy at pioneering biotech companies, and contributed to peer-reviewed publications shaping national precision oncology guidelines.A proud Texan and SMU alumna, she is devoted to building the future of compassionate, data-driven cancer care—and scaling access to life beyond diagnosis.

For media, strategic partnerships, or investor relations:
contact@sanareoncology.com

Frequently asked questions

Got questions? We’ve got answers.

Who can benefit from Sanare Oncology?

Our services are ideal for cancer survivors, individuals at high risk of developing cancer, those undergoing treatment who need additional support, and anyone looking for expert oncology care outside of traditional hospital settings.

How can Sanare Oncology help with cancer prevention?

We provide genetic risk assessments, lifestyle modification guidance, personalized screening plans, and ongoing health monitoring to reduce your risk of cancer.

Do you offer genetic testing for cancer risk?

While we don’t conduct testing in-house, we partner with leading laboratories to facilitate genetic testing and help interpret results, offering guidance on risk-reduction strategies.

What lifestyle changes can lower my cancer risk?

Our team provides personalized recommendations on nutrition, exercise, stress management, and toxin avoidance to help reduce your cancer risk.

Can you recommend cancer screenings for me?

Yes! Based on your personal and family medical history, we create a customized screening schedule to ensure early detection of potential cancer risks.